Researchers at Mayo Clinic may have discovered a new approach to tackling age-related cognitive decline.
Their recent study suggests that removing senescent cells from aging mice can improve cognitive function.
What are senescent cells?
Imagine a group of stubborn invaders in your body.
These are senescent cells—cells that were supposed to die naturally, but refuse to clear out.
These cells are stuck, preventing new cells from replacing them, do not divide, and cause significant damage by releasing toxins.
Causes of senescent cell formation:
- DNA damage: Damage from oxidation, radiation, or toxins can cause cells to become senescent.
- Telomere shortening: Telomeres are protective "caps" at the ends of chromosomes. Their shortening with age or due to other factors can lead to cell senescence.
- Disruptions in cellular pathways: Impairment of mechanisms regulating cell death can cause cells to avoid death and become senescent.
Negative effects of senescent cells:
- Chronic inflammation: Senescent cells release cytokines, molecules that promote inflammation.
Chronic inflammation is linked to various diseases, such as cardiovascular disease, cancer, and diabetes. - Tissue damage: Senescent cells damage healthy tissues around them, impairing their function.
- Aging: The accumulation of senescent cells in tissues contributes to the aging process and age-related diseases.
The link between senescence and cognitive decline
Many factors contribute to cognitive decline as we age, including chronic inflammation. This study examines the connection between senescent cells and cognitive decline.
Mayo Clinic study: A two-step approach
Dr. Diana Jurk and her team took a dual approach to investigate the possibility of reversing cognitive decline.
They examined the genetic response to senolytic drugs (pharmacogenomics) and the effectiveness of drug delivery strategies (pharmacology).
Identifying the culprits: Microglial cells and oligodendrocyte progenitor cells
Previous studies linked senescent cells to the brain, but the specific cell types affected by aging remained a mystery.
Dr. Jurk's team used single-cell RNA sequencing, a powerful technique that reveals gene expression in thousands of individual cells.
This method identified microglial cells and oligodendrocyte progenitor cells as the main suspects in senescence during aging.
Clearing senescent cells, restoring cognitive function
The researchers used two senolytic methods to eliminate senescent cells in genetically aging mice:
- AP20187: Targets p16-positive senescent cells
- A cocktail of Dasatinib and Quercetin
Both methods significantly improved cognitive function in mice compared to pre-treatment tests.
A ray of hope for future treatments
The success of the study in mice provides a solid foundation for future research on removing senescent cells as a potential treatment for age-related cognitive decline in humans.
It builds on previous Mayo Clinic research showing similar benefits in a mouse model of Alzheimer's disease and on Dr. Jurk's earlier work on senescent cells and anxiety.
Unanswered questions and next steps
While the results are promising, several key questions remain:
- How do senescent cells contribute to brain aging?
- Since the treatment was systemic, which specific senescent cells were targeted?
- How did this intervention affect immune system cells in the modified mice?
Further cognitive function tests are needed to strengthen these findings.
.
References:
💬 Comments (0)
Be the first to comment on the article.